Factors associated with complications in ST-elevation myocardial infarction: a single-center experience

30/09/2023 2 min

Listen "Factors associated with complications in ST-elevation myocardial infarction: a single-center experience"

Episode Synopsis

  
Factors associated with complications in ST-elevation myocardial infarction: a single-center experience
BMC Cardiovasc Disord 2023 Sep 19;23(1):468.
 
Abstract
Background: ST-elevation myocardial infarction (STEMI) is a major public health problem. This study aimed to determine the
prevalence and identify the determinants of STEMI-related complications in the Cardiology Intensive Care Unit of the Sud Francilien Hospital Center (SFHC).
 Methods: We retrospectively analyzed the data of 315
patients with STEMI aged ≥ 18 years. Logistic regression was used to identify factors independently associated with the occurrence of complications.
 Results: Overall, 315 patients aged 61.7 ± 13.4
years, of whom 261 were men, had STEMI during the study period. The hospital frequency of STEMI was 12.7%. Arrhythmias and acute heart failure were the main complications. Age ≥ 75 years (adjusted odds ratio [aOR], 5.18; 95% confidence
interval [CI], 3.92-8.75), hypertension (aOR, 3.38; 95% CI, 1.68-5.82), and cigarette smoking (aOR, 3.52; 95% CI, 1.69-7.33) were independent determinants of acute heart failure. Meanwhile, diabetes mellitus (aOR, 1.74; 95% CI, 1.09-3.37), history of atrial fibrillation (aOR, 2.79; 95% CI, 1.66-4.76), history of stroke or transient ischemic attack (aOR, 1.99; 95% CI, 1.31-2.89),
and low high-density lipoprotein-cholesterol (HDL-C) levels (aOR, 3.70; 95% CI, 1.08-6.64) were independent determinants of arrhythmias.
 Conclusion: STEMI is a frequent condition at SFHC and
is often complicated by acute heart failure and arrhythmias. Patients aged ≥ 75 years, those with hypertension or diabetes mellitus, smokers, those with a history of atrial fibrillation or stroke, and those with low HDL-C levels require careful monitoring for the early diagnosis and management of these
complications.

Disclaimer:
Lupin makes no representation or warranty of any kind,
expressed or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any scientific information shared by the HCP on the ­­­STAR UPDATE podcast. You should not allow the contents of this to substitute for your own medical judgment, which you should exercise in
evaluating the information on this website.




































More episodes of the podcast Star Update Podcast - Cardiology News Summaries